The S1P receptor 1 antagonist Ponesimod reduces TLR4-induced neuroinflammation and increases Aβ clearance in 5XFAD miceResearch in context - Zhihui Zhu; Liping Zhang; Ahmed Elsherbini; Simone M. Crivelli; Priyanka Tripathi; Carmen Harper; Zainuddin Quadri; Stefka D. Spassieva; Erhard Bieberich (EBioMedicine, 2023)